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Abstract 
There are many guidelines that guide the management of patients with MOM hips.  
We looked to compare the differences in management of patients with MOM hips 
from around the world.  
Six international tertiary referral orthopaedic centres were invited to participate 
by organising a multi-disciplinary panel consisting of 2 or more hip surgeons and 
a musculoskeletal radiologist. A full clinical dataset including history, blood tests 
and imaging for 10 patients was sent to each unit, hence all 6 units discussed the 
same 10 cases. Differences in the interpretation of findings, management decision 
and rationale for decisions were compared using quantitative and qualitative 
methods. 
Overall agreement between orthopaedic centres recommending treatment on the 
management of patients with MOM hip implants was moderate (kappa = 0.6). Full 
agreement was seen in a third of cases, however split decisions were also seen in 
a third of cases.  Units differed in their interpretation of investigation findings, and 
put varying emphasis on serial changes in the presence of symptoms. 
In conclusion, the management of raised or rising blood metal ions, cystic 
pseudotumours and peri-acetabular osteolysis led to inconsistent agreement 
between centres. Coordinated international guidance and MDT panel discussions 
are recommended to improve consensus in decision-making. 
Introduction 
Protocols are in common use to help efficiently manage patients with common 
problems.  There are many protocols that guide the management of patients with 
MOM hips [1-3].  We sought peer review for our new approach [4], because these 
protocols are insufficient.  
The early failure of metal on metal (MOM) hip implants has the potential to impact 
over 1 million patients worldwide.  The rise in revision rates of patients with MOM 
hips as demonstrated by various national joint registries highlights this problem 
[5, 6].  Further to this, the average cost of aseptic revision is estimated at over 
£12,000 in the UK, putting a significant financial burden on the NHS [7].  However 
deciding “who”, “when” and “how” revision should be performed is still an area of 
debate.  
The UK regulatory agency (Medicines and Healthcare Products Regulatory 
Agency, MHRA) was the first to issue management guidelines for all MOM hips in 
2010 [1]. This was followed by guidance from the FDA (Food and Drug 
Administration) in 2012 [8], and more recently by the European regulatory bodies 
(Scientific Committee on Emerging and Newly Identified Health Risks, SCENIHR) 
[9]. This guidance is essential to simplify decision-making.  However, the advice 
given by each regulator varies slightly, and in some cases does not fully define how 
various tests are to be interpreted and therefore the recommended course of 
action.   
The use of Multi-Disciplinary Teams (MDT) have recently been developed with the 
aim of using surgical experience and evidence based current best practice to 
reduce the uncertainty surrounding the management of patients with MOM hip 
implants. It is believed that MDTs improve decision-making and lead to superior 
outcomes for patients [4, 10, 11], particularly since a panel of experts can pool 
knowledge and experience in providing a balanced viewpoint. 
Our aim was to understand the degree of variability in management decisions for 
patients with MOM hip implants across the world. We had three objectives, (1) to 
recruit five orthopaedic centres of excellence across the UK, Europe and the USA, 
who have experience in managing MOM hip patients, (2) to compare the 
management decision of these units with our own when discussing the same 
patients, and (3) to analyse the similarities and differences in the management 
decisions using both quantitative and qualitative methods. 
Methods 
Summary 
We conducted an international multi-centre comparative study to assess the 
similarities / differences in management of MOM hip patients with a variety of 
symptoms and complications.   There were 3 stages to our methods, which 
included (1) patient selection, (2) invitation to orthopaedic centres to collaborate 
and, (3) analysis of outcomes using both quantitative and qualitative methods. 
Patient Selection 
10 patients were recruited from the base hospital, the Royal National Orthopaedic 
Hospital (RNOH) United Kingdom, a tertiary referral centre that employs a Multi-
Disciplinary Team (MDT) to discuss patients with MOM hips [4].  The MDT team 
consists of four revision hip surgeons, a musculoskeletal radiologist, and a nurse 
coordinator, which meet on a regular basis and have discussed over 300 cases 
since August 2012.  
Patients were selected from the database of cases discussed at the RNOH MDT. 
Patients were selected to demonstrate a full spectrum of clinical dilemmas.  Four 
categories of patients were selected: 
1) Metal ion dilemmas  
2) Bone abnormalities 
3) Soft tissue abnormalities 
4) Other / Combined abnormalities 
Details of the cases are summarized in table 1. Patient demographics; clinical 
history, examination findings and serology results were collected. Patients were 
only selected if sufficient clinical information required to make informed decisions 
on clinical management was available.  All relevant imaging, including x-ray, 
computed tomography, and magnetic resonance images were obtained.  
Patient details and imaging were anonymised prior to sharing with collaborating 
orthopaedic centres.  Sharing of information was conducted using secure 
protocols. 
Recruitment of Orthopaedic Centres of Excellence 
Five international orthopaedic centres of excellence were invited to participate in 
this study. Each centre was asked to mobilise an MDT panel similar to that used in 
the base hospital.  Minimum requirements for the MDT panel were 2 or more hip 
revision surgeons, and a musculoskeletal radiologist. 
The collaborating orthopaedic centres consisted of Massachusetts General 
Hospital (Boston, Massachusetts, USA), Hospital for Special Surgery (New York, 
USA), Wrightington Hospital (Wigan, UK), COXA Hospital for Joint Replacement 
(Tampere, Finland) and the Endoklinik (Hamburg, Germany). 
Each centre was sent an identical patient pack, which included the clinical details 
of the patients to be discussed and the appropriate imaging for each patient.  The 
centres were sent a structured questionnaire that asked them to comment on the 
patients’ symptoms, implant type, serology results, imaging 
findings/interpretation followed by a management decision and a rationale 
supporting the choice of treatment for each patient.  
Analysis of results 
Quantitative (Statistical) Analysis 
Each of the six orthopaedic centres provided a management decision for the 10 
patients, therefore a total of 60 clinical decisions were available for comparison.  
The management decisions were categorized into either (1) Monitor, (2) Further 
investigation and (3) Revision surgery.  This categorization was used to aid 
quantitative analysis.   
Inter-unit agreement (Cohen's Kappa) was run to determine if there was 
agreement between the six orthopaedic centres regarding management decisions.  
Further to this, the distribution of ratings over the six centres was compared for 
each of the 10 clinical scenarios using a cumulative multinomial distribution 
calculation.  Significance was assumed if the p = value was ≤0.05. All statistical 
analysis was performed using SPSS version 21 statistical package (IBM, NY, USA). 
 
Qualitative (Thematic) Analysis 
All 60 clinical decisions were analysed using thematic analysis, and the 
concordance of themes across the 6 centres for each of the 10 patients was 
reported. Thematic analysis is used in qualitative research and focuses on 
pinpointing, examining, and recording patterns (or "themes") within data to 
understand certain actions, in this case decision-making [12].  
The analysis was performed through the process of coding and thematisation in 
five phases.  These phases were:  
1) Reviewing of anonymised MDT transcription data (each read twice) 
2) Generation of initial codes from the data 
3) Searching for themes among these initial codes (focused themes) 
4) Reviewing themes (frequency and concordance of themes amongst the full 
data set) 
5) Production of the final report by applying theory to help explain the 
themes. 
Table 2 demonstrates an example of thematic analysis as applied in this process. 
This is a systematic, evidence-based method of analysis that can produce 
quantifiable results along with interpretive analysis. 
Results 
Overall agreement between orthopaedic centres recommending treatment on the 
management of patients with MOM hip implants was moderate. However, metal 
ion thresholds, including rising levels, treatment for pseudotumours and 
osteolysis still lead to a variation in management across the world.  
Quantitative analysis 
Each of the six orthopaedic units employed an MDT team to consider each patient 
and accordingly provided a treatment recommendation. Table 2.   
Inter-unit agreement, when comparing the treatment recommendations, achieved 
a moderate agreement (κ = 0.6, p = 0.21), using the Landis and Koch criteria [13]. 
In-depth analysis demonstrated that 100% agreement in management decisions 
was achieved for only 3 patients. 5 out of 6 units recommended a similar treatment 
regime in 4 patients (83% agreement). However, of the remaining 3 patients, 4 out 
of 6 units agreed treatment (67%) in 2 patients and a split decision was seen in 
the final patient (33% agreement). Table 3.  The distribution of treatment 
recommendations for each patient was assessed using cumulative multinomial 
distribution.  The obtained distribution of ratings significantly differed from 
chance in all-but-one clinical scenario, where no true agreement between the units 
was seen (patient 7 p>0.05). The reasons for discordance between the 
orthopaedic units were further explored using thematic qualitative analysis. 
Qualitative analysis 
This section refers to the feedback provided by each orthopaedic unit regarding 
each patient.  These were systematically analysed to understand the rationale 
provided by each MDT for the treatment recommendations made.  Table 4. 
Despite the moderate inter-unit agreement, there remained considerable 
variation in certain patients. We focused on the patients with low agreement levels 
in order understand the reasons for discordance. 
Patient 7 – Split Decision 
There was a high level of discordance in treatment recommendations for this 69-
year-old male patient with bilateral well functioning hip resurfacings.  All units 
agreed that the patient possessed low risk implants and minimal symptoms.  
However, units put varying degrees of emphasis on the rising metal ion levels 
(cobalt 6.7 to 9.8ppb) and the high inclination of the cup as seen on Xray.  
Figure 1a.  
The two units recommending simple follow up felt the rise in metal ions was not 
significant in a patient with bilateral MOM hip implants, and were reassured by 
the lack of symptoms in an active patient.  The two units recommending revision 
surgery, did so on the premise that the cup of the left hip had an excessive 
inclination, which in the presence of rising metal ion levels and small fluid 
collection seen within the soft tissues mandates revision surgery. Figures 1b. 
Patient 4 – 67% agreement 
A female patient with bilateral MOM hip implants, both of which are functioning 
well with minimal symptoms (OHS 45-47).  Blood metal ion (cobalt 2.5ppb) levels 
were well below the MHRA threshold and imaging including MRI revealed peri-
acetabular osteolysis. Figure 2. 
All units commented on the risk profile of the implants in this patient: 
“Minimally symptomatic in female patient with recalled MOM right total hip 
replacement and asymptomatic resurfacing in the left hip” 
All units commented on the low metal ion levels. Five units commented on the 
peri-acetabular osteolysis affecting the right hip more than the left. Of these five 
units, three requested a CT scan, one requested repeat Xray and the fifth an MRI 
scan, in order to define the pathology further.  However, two units committed to 
early revision for the following reason: 
“Severe peri-acetabular bone loss, will progress leading to more 
complicated surgery therefore revise early. CT required to evaluate this in 
3D” 
Patient 8 – 67% agreement 
This patient was a 75-year-old female with a right sided hip resurfacing. Metal ion 
levels were moderately raised although the interval change was minimal (cobalt 
6.0 to 7.5ppb).  Serial MRI revealed evidence of synovitis and pseudotumour, 
however these were unchanged on serial imaging over 2 years. Figure 3a and 3b.  
Four units advised revision based on the soft tissue changes and the rising metal 
ion levels.  However, two units emphasised that changes were relatively stable on 
serial assessment and therefore recommended follow up instead, but did 
recognize that revision in the future was likely.  
 
Discussion 
We compared the management of MOM hip patients across a collaborative 
international group of orthopaedic centres of excellence.  We demonstrated a 
moderate inter-unit agreement, however, commonly encountered clinical 
scenarios still split opinions on the best form of management to offer. We used 
quantitative methods to highlight any differences, followed by qualitative 
research methods to understand the factors leading to the variation in decision-
making.  Areas of contention were interplay between patient function and 
investigation findings, particularly for: 
Rising metal ions 
Management of osteolysis 
Revision for pseudotumour 
There appears to be considerable debate as to the best management of patients 
with failing/symptomatic MOM hip implants. International regulatory authorities 
have published guidance for surgeons [1-3, 8]. Guidelines are most appropriate 
for situations in which there is little variability among cases and a strong evidence 
base, both of which are lacking when considering the long-term outcomes of 
patients with MOM hip implants. To compound this further, variation between the 
various guidelines leads to differences in the management of patients on the 
frontline.  This variation reflects the lack of evidence supporting the guidance. 
Metal ion levels remain an area of contention.  Currently the threshold for concern 
as set out by the MHRA is 7ppb. However, since the 7ppb level was derived from 
research based on hip resurfacings [14], it has been postulated that this may not 
apply to stemmed implants.  A study including a variety of implant types 
demonstrated improved sensitivity and specificity with a cobalt level of 4.5ppb in 
stemmed implants [15].  Thresholds for revision are not clearly defined.  A recent 
study demonstrated that a metal ion level should not be used in isolation to 
determine the need for revision, but what was clear was that higher levels of blood 
metal ions were a strong predictor of a failing MOM hip implant [16]. Predictably 
metal ion levels do fall after revision [17, 18]. 
In this study, some units reported poor cup position in relation to raised or rising 
metal ion levels as a cause for concern, leading to the recommendation of hip 
revision surgery.  However cup position has been shown to be a poor predictor of 
failure and does not correlate with metal ion levels [19, 20].    
Revision for pseudotumour is also poorly defined.  Pseudotumours can exist in 
symptomatic and asymptomatic patients [21, 22].  What is relevant is whether 
pseudotumours progress over time, and several studies have attempted to report 
this, however this remains inconclusive [23-27].   
The presence of osteolysis surrounding MOM hip implants appears to be under-
reported as a consequence of metal debris [28].  The morphology of bone may be 
affected by cobalt and chromium through effects on osteoblasts and osteoclasts, 
which may ultimately lead to osteolysis [29-31].  As a subsequent complication, 
poor bone in-growth and therefore failure of fixation of revision acetabular cups 
has been reported after revision MOM hip surgery [32].    
The use of multidisciplinary teams (MDT) have been shown to be an effective tool 
in aiding surgeons to manage MOM hip patients with complex problems [4]. The 
benefits of MDT meetings are higher-quality decision-making and improved 
outcomes through the ability of a panel of experts to pool knowledge and 
experience in providing a balanced viewpoint. An expert panel can offer their 
combined tacit knowledge and experience of hip revision surgery when making 
recommendations; such knowledge and experience cannot be transmitted in any 
written guideline.   
Despite this, variation between different MDT management plans further 
highlights the need for better guidance as seen in this study.  However, lack of 
guidance may not be the only reason for the variation seen, since each unit will 
have a uniquely different experience in the management of MOM hip implants.  
This experience is summarised in Table 5, and demonstrates that each unit has 
extensive experience, however considerable variation exists in the number of 
primaries implanted.  Each unit has revised a similar number of cases except for 
the COXA unit, which has a large burden of ASR (Depuy Synthes, Warsaw, Indiana) 
implants that have been revised.  It is sensible to conclude that such variation in 
operative experience, the implants used and revision techniques utilised by 
individual units will have a bearing on the decision made in the MDT setting.  
Furthermore, the effect of this differing experience and its impact on the variation 
in management seen in this study is difficult to assess, and certainly the resulting 
effect on patient outcome is not possible to quantify. 
Future consensus will only be achieved with large-scale clinical trials and long-
term follow-up studies. However, since the majority of MOM hip implants are no 
longer in use, and the “at risk” cohort of patients is steadily declining, the 
likelihood of large scale studies being conducted is small. It would be logical to 
assume that variation between individual surgeons would be much greater given 
the demonstration of inter-unit MDT variation here.  Therefore, shared decision-
making, as in the MDT approach, is likely to reduce outlier activities of individual 
surgeons. 
One disadvantage of an MDT meeting is the disconnection between the patient’s 
wishes and the opinion of the expert panel, which can sometimes be overlooked.  
This was seen for patient 10, where the patient had expressed a desire to avoid 
surgery. Five units subsequently recommended surgery and therefore overlooked 
this in the patient’s history. It is important to recognise the need for shared 
decision-making, between the patient and the surgeon.  One centre within this 
study, offered a primary management plan followed by an alternative 
management plan should the patient not agree. This should be a feature of such 
MDT meetings. 
Before embarking on this study, it was hypothesised that variation existed 
depending on the guideline being followed, where the national regulatory 
authority guides each centre.  However variation between units within the same 
country disproved this hypothesis.  Instead the use of thematic analysis helped us 
to identify the reasons for discordance on a case-by-case basis.  
Conclusion 
Variation exists in the management of MOM hip patients. A lack of adequate 
evidence for some themes used to justify decision-making in the management of 
MOM hip implants provides a strong rationale for the use of an MDT approach for 
these patients.  This reduces the likelihood of outlier decision-making in the 
absence of uniform guidance.    
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 Pt 
1 2 3 4 5 6 7 8 9 10 
Metal Ion Dilemmas Bone Soft Tissue Dilemmas Other 
 
Age 
 
71 
 
64 
 
56 
 
49 
 
75 
 
76 
 
69 
 
75 
 
61 
 
67 
Sex M M F F F F M F F M 
Implant THR THR HRA R-THR / L-HRA THR THR HRA HRA THR THR 
Laterality Right Bilateral Bilateral Bilateral Left Right Bilateral Right Right Left 
Time in-situ 
(months) 
90 R88/L90 R84/L114 R102/L129 95 91 R133/L127 92 68 92 
OHS 47 48 R22/L42 R47/L45 29 31 R43/L47 24 6 44 
Cobalt 6.2 12.1 54.2 2.5 5.4 1.0 6.7 » 9.8 6.0 » 7.5 22.0 9.5 
Chromium 4.4 3.6 26.0 2.7 6.3 0.7 7.2 » 8.7 3.3 » 4.1 12.0 2.2 
CRP 1 1 9 1 2 8 1 11 12 6 
Symptoms Mobile and 
happy. Twinge 
on bending.  
Unlimited 
activities. 
Excellent 
function, 
occasional pain 
right thigh. 
Right – 
Constant ache, 
walking 
distance 
limited. Left – 
no symptoms 
Right – hip 
aches after 
long periods of 
use. Left – 
occasional 
pain, difficulty 
bending 
Pain 
worsening 
since 
operation. 
Leg length 
unequal (long 
on left). Uses 
stick to 
mobilise. 
Pain in groin, 
walks short-
legged gait. 
Pain on 
turning. 
 
(Multiple 
medical co-
morbidities) 
Right – 
episodic lateral 
hip pain, 
previous 
subluxations 
improved with 
cycling. Left – 
occasional 
ache. 
 
Uses crutches 
outdoors, some 
clicking in hip. 
Occasional 
pain to 
anterior thigh. 
Well 
functioning for 
5 years, now 
developed 
groin and 
buttock pain. 
Painless hip, 
however 
palpable groin 
lump. Active 
and mobile. 
Examination Pain free ROM. Pain free ROM Right – painful 
flexion. Left – 
Full ROM 
Right – Pain 
free. Left – 
painful ROM. 
Good ROM, 
painful over 
trochanter 
Painful ROM Full pain free 
ROM. 
Slight 
restriction to 
ROM 
Full ROM, 
irritable on 
rotation 
Palpable 
anterior groin 
lump.  Good 
ROM. 
 
MRI  Effusion and 
mild synovitis 
 
Effusion and 
moderate 
synovitis 
Effusion and 
moderate 
synovitis 
Superior pubic 
ramus 
osteolysis 
(right) 
Left cystic PS 
with 
disruption of 
abductor 
attachment 
Posterior 
cystic PS 
Fluid over left 
Greater 
Trochanter 
Cystic PS 
anterior and 
posterior to 
hip (stable on 
serial exam) 
Right hip 
synovitis, Left 
hip anterior 
cystic PS 
Anterior cystic 
PS with 
interval 
increase in 
debris 
contents 
Patient 
Expectation 
 
Will be advised Keen to avoid 
surgery 
Will be advised Will be advised Will be advised Will be advised Will be advised Will be advised Will be advised Keen to avoid 
surgery 
Table 1: Demographic, clinical and imaging details for the patient cohort studied. Note Cobalt and Chromium given in Parts Per Billion.  MRI = Magnetic Resonance Imaging, OHS = Oxford hip Score (max = 
48), CRP = C-Reactive Protein, PS = Pseudotumour, Sex M = male, F = female, THR = Total Hip Replacement, HRA = Hip Resurfacing Arthropalsty, ROM = Range of Movement.
  
Stages of thematic Analysis 
 
Raw Data Initial Codes Focused Themes Review Application of 
Theory 
 
This is a 67-
year-old female 
with a modular 
total hip 
replacement, 
which is a high-
risk implant. She 
complains of 
constant pain, 
and is limited in 
her function.  
Her metal ion 
levels are raised 
(10ppb) and 
there is evidence 
of a 
pseudotumour 
on MRI 
scanning.  We 
recommend 
revision surgery. 
 
Comment on 
patients 
demographics 
 
Type of implant 
and its risk 
profile 
 
Patients 
symptoms 
including 
functional status 
 
Quantification of 
metal ion levels 
 
Findings on 
cross sectional 
imaging -
pseudotumour 
 
 
 
 
Patient 
demographic 
 
High risk 
implant  
 
Symptomatic 
 
High blood 
metal levels 
 
Imaging findings 
- pseudotumour 
 
 
 
 
 
 
Frequency of 
themes across 6 
centres 
 
Degree of 
agreement 
between 
centres 
 
 
 
Application to 
current evidence 
base to prepare 
final report: for 
example the 
current 
threshold for 
concern of metal 
ions 
recommended 
by the MHRA is 
7ppb 
Table 2: A simplified representation of the application of thematic analysis used to understand the 
rationale behind management decision-making  
 
 
 
Pt RNOH COXA ENDO Wright MGH HSS Majority 
Agreement 
(%) 
P 
1 Investigate Investigate Investigate Investigate Investigate Monitor 83 0.01 
2 Investigate Investigate Investigate Investigate Investigate Investigate 100 <0.01 
3 Revise Revise Revise Revise Revise Revise 100 <0.01 
4 Investigate Investigate Revise Revise Investigate Investigate 67 0.03 
5 Revise Revise Investigate Revise Revise Revise 83 0.01 
6 Investigate Investigate Revise Investigate Investigate Investigate 83 0.01 
7 Monitor Investigate Investigate Revise Monitor Revise 33 >0.05 
8 Monitor Revise Revise Revise Monitor Revise 67 0.03 
9 Revise Revise Revise Revise Revise Revise 100 <0.01 
10 Investigate Revise Revise Revise Revise Revise 83 0.01 
 
Table 3: The final management decision recommended by each orthopaedic centre. The associated 
agreement for each patient, followed by the statistical significance calculated using cumulative 
multinomial distribution analysis. 
 
 
Pt Focused Themes Outcome Frequency Max total = 6 
1 Asymptomatic / minimal in all 
High risk implant  
Blood Ions moderately raised  
Minimal imaging finding on MRI (effusion) 
Possible osteolysis on xray 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other  
All  
5  
2  
1  
0  
- 
2 Symptoms (occasional) 
High Risk Implant 
Elevated Co:Cr Ratio 
Pedestal distal to stem on Xray  
MRI shows synovitis 
Possible taper corrosion 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
All 
All 
0 
3 
0 
Hip aspiration 
3 Low risk implants 
Right side symptoms 
Small head size 
Sub-optimal cup position  
High ions 
Fluid collection 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
- 
- 
- 
- 
All 
- 
4 Minimal symptoms 
Low metal ions 
Sub-optimal cup position on left 
Osteolysis both hips - ARMD 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
4 
0 
1 
1 
2 
3 requested CT 
5 High risk implant 
Symptomatic 
Moderate ion levels 
High offset hip 
Surgical approach related muscle damage 
Pseudotumour and muscle damage 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
1 
1 
0 
0 
5 
- 
6 High risk implant 
Symptomatic 
Pseudotumour 
Muscle atrophy 
Xray suggests loose stem 
Oversized head 
Multiple co-morbidities 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
5 
1 
0 
3 
1 
Hip aspiration 
7 Low risk implants 
Left suboptimal cup position 
Occasional subluxations of right hip 
Rising metal ions 
Small fluid collection left 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
4 
3 
0 
1 
2 
- 
8 Low risk implants 
Poor OHS and mechanical symptoms 
Xrays satisfactory 
Rising metal ions 
Fluid / PS that is stable on MRI 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
2 
0 
0 
0 
4 
- 
9 High risk implant 
New onset symptoms 
High ions 
High CRP 
Mild changes on MRI 
Aspirate hip to rule out infection 
Revise early to protect soft tissues 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
- 
- 
- 
- 
All 
Aspirate prior to 
revision (4) 
10 High risk implant 
Asymptomatic 
Palpable mass anterior to hip 
High Co:Cr ratio 
Pseudotumour anteriorly corresponds to clinical 
findings 
Serial imaging – stable over time 
Patient not keen on surgery 
Follow up 
Repeat blood tests 
Repeat Xray 
Repeat MRI 
Revise 
Other 
1 
0 
0 
0 
5 
- 
 
Table 4: Results of thematic analysis – this table demonstrates the common focused themes for each patient as provided 
by each centre, and also includes a breakdown of the management outcome. 
  
 RNOH COXA ENDO Wright MGH HSS 
Total MOM Primaries 480 2868 0 468 100 2200 
Total MOM Revisions 400 600 250 220 450 300 
All Hip Revisions/yr 300 400 1200 300 500 500 
 
Table 5: Demonstrates the variation in experience of each of the six units participating in this study.  
This includes total MOM hip primaries implanted, total MOM hips revised and all hip revisions 
undertaken yearly.  
 
 Figure 1a: Anteroposterior pelvis radiograph for patient 7. The left acetabular cup 
appears to have an excessive inclination 
 
 
 
Figure 1b: Axial T2 weighted MARS MRI for patient 7.  Yellow arrow demonstrates 
a small fuid collection over the left greater trochanter. 
 
 
 
 
Figure 2: Anteroposterior pelvis radiograph (patient 4) – demonstrating peri-
acetabular osteolysis particularly affecting the right hip 
 
  
 
Figure 3a: T2 weighted Axial MRI images for patient 8, demonstrating stable 
appearances to the cystic pseudotumour (arrow) over a 2-year period from 2012 
(3a) to 2014 (3b) 
 
. 
 
Figure 3b: T2 weighted Axial MRI images for patient 8, demonstrating stable 
appearances to the cystic pseudotumour (arrow) over a 2-year period from 2012 
(3a) to 2014 (3b) 
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Table 1: Demographic, clinical and imaging details for the patient cohort studied. 
Note Cobalt and Chromium given in Parts Per Billion.  MRI = Magnetic Resonance 
Imaging, OHS = Oxford hip Score (max = 48), CRP = C-Reactive Protein, PS = 
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Resurfacing Arthropalsty, ROM = Range of Movement. 
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significance calculated using cumulative multinomial distribution analysis. 
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Figure 3a: T2 weighted Axial MRI images for patient 8, demonstrating stable 
appearances to the cystic pseudotumour (arrow) over a 2-year period from 2012 
(3a) to 2014 (3b) 
 
Figure 3b: T2 weighted Axial MRI images for patient 8, demonstrating stable 
appearances to the cystic pseudotumour (arrow) over a 2-year period from 2012 
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